Cargando…

Diversity index as a novel prognostic factor in breast cancer

Intratumoral genetic heterogeneity leads to tumor progression and therapeutic resistance. However, due to the difficulty associated with its assessment, the use of this heterogeneity as a prognostic or predictive marker remains limited. To investigate the significance of the Shannon diversity index...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Yul Ri, Kim, Hyun Jeong, Kim, Young A., Chang, Mee Soo, Hwang, Ki-Tae, Park, So Yeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722549/ https://www.ncbi.nlm.nih.gov/pubmed/29228597 http://dx.doi.org/10.18632/oncotarget.21371

Ejemplares similares

Clinical implications of changes in the diversity of c-MYC copy number variation after neoadjuvant chemotherapy in breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2018)

Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
por: Woo, Ji Won, et al.
Publicado: (2019)

Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer
por: Ahn, Soomin, et al.
Publicado: (2020)

Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast
por: Kim, Milim, et al.
Publicado: (2020)

Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers
por: Woo, Ji Won, et al.
Publicado: (2020)

MicroRNA-222 Expression as a Predictive Marker for Tumor Progression in Hormone Receptor-Positive Breast Cancer
por: Han, Song-Hee, et al.
Publicado: (2017)

Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2021)

A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method
por: Jang, Min Hye, et al.
Publicado: (2017)

Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast
por: Kim, Milim, et al.
Publicado: (2021)

Prognostic Role of KRAS mRNA Expression in Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2019)

Prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2021)

Prognostic Influence of BCL2 on Molecular Subtypes of Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2017)

Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience
por: Kim, Milim, et al.
Publicado: (2018)

Mammary Carcinoma Arising in Microglandular Adenosis: A Report of Five Cases
por: Kim, Mimi, et al.
Publicado: (2017)

A Prognostic Model for Patients with Triple-Negative Breast Cancer: Importance of the Modified Nottingham Prognostic Index and Age
por: Kwon, Jeanny, et al.
Publicado: (2017)

Influence of Androgen Receptor on the Prognosis of Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2020)

Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer
por: Han, Song-Hee, et al.
Publicado: (2022)

Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer
por: Ahn, Soomin, et al.
Publicado: (2018)

Interobserver Variability of Ki-67 Measurement in Breast Cancer
por: Chung, Yul Ri, et al.
Publicado: (2016)

Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer
por: Chung, Il Yong, et al.
Publicado: (2017)

The prognostic value of the nodal ratio in N1 breast cancer
por: Han, Tae Jin, et al.
Publicado: (2011)

The Body Mass Index as a Prognostic Factor of Critical Care
por: Lim, So Yeon, et al.
Publicado: (2010)

Microinvasive Carcinoma versus Ductal Carcinoma In Situ: A Comparison of Clinicopathological Features and Clinical Outcomes
por: Kim, Milim, et al.
Publicado: (2018)

Prognostic Influence of Preoperative Mammographic Breast Density in Operable Invasive Female Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2018)

Metachronous Sporadic Sextuple Primary Malignancies Including Bilateral Breast Cancers
por: Hwang, Ki-Tae, et al.
Publicado: (2020)

Prognostic Influence of Preoperative Fibrinogen to Albumin Ratio for Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2017)

Prognostic influence of Korean public medical insurance system on breast cancer patients
por: Hwang, Ki-Tae, et al.
Publicado: (2019)

Prognostic Implication of Focal Breast Edema on Preoperative Breast Magnetic Resonance Imaging in Breast Cancer Patients
por: Sung, Pamela, et al.
Publicado: (2023)

The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2018)

Effects of Fermented Artemisia annua L. and Salicornia herbacea L. on Inhibition of Obesity In Vitro and In Mice
por: On, Jeong-Yeon, et al.
Publicado: (2023)

Prognostic Significance of CD109 Expression in Patients with Ovarian Epithelial Cancer
por: Kim, So Young, et al.
Publicado: (2019)

Diverse Immunoprofile of Ductal Adenocarcinoma of the Prostate with an Emphasis on the Prognostic Factors
por: Jeong, Se Un, et al.
Publicado: (2017)

Primary malignant rhabdoid tumor of greater omentum in 10-year-old girl
por: Nam, So-Hyun, et al.
Publicado: (2014)

Is bone mineral density a prognostic factor in postmenopausal women with luminal A breast cancer?
por: Lee, Seungju, et al.
Publicado: (2023)

Identification of Prognostic Risk Factors for Transient and Persistent Lymphedema after Multimodal Treatment for Breast Cancer
por: Kim, Myungsoo, et al.
Publicado: (2016)

Clinical impact of body mass index on bactibilia and bacteremia
por: Bang, Chang Seok, et al.
Publicado: (2014)

Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer
por: Han, Wonshik, et al.
Publicado: (2006)

Prognostic value of ERBB4 expression in patients with triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2016)

Role of serum bilirubin-to-albumin ratio as a prognostic index in critically ill children
por: Kang, You Min, et al.
Publicado: (2022)

Diagnostic Performance of %[-2]proPSA and Prostate Health Index for Prostate Cancer: Prospective, Multi-institutional Study
por: Park, Hongzoo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k4cb73kfoa93velkv122m6vdcc